Unraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA)

Clinical trial NCT03829306 · COMPLETED

Trial details

NCT number: NCT03829306
Sponsor: Spanish Breast Cancer Research Group
Status: COMPLETED
Study type: OBSERVATIONAL

Advanced Breast Cancer

Start date: 2018-06-12
Primary completion: 2022-06-21
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.